Key result
Contrary to historical beliefs, percutaneous closure is now a viable option for up to 75% of superior sinus venosus atrial septal defects, facilitated by transesophageal echocardiography.
Answers are grounded in this paper and cite their sources.
Highlights that percutaneous closure is now a viable option for many patients with superior sinus venosus atrial septal defects, correcting a previous statement that they were not amenable to such treatment.
The paper by Qiu et al.1Qiu J.K. Bamira D. Vainrib A.F. Latson L.A. Halpern D.G. Chun A. et al.Multimodality imaging of sinus venosus atrial septal defect: a challenging diagnosis in adults.Cardiovasc Imaging Case Rep. December 31, 2021; https://doi.org/10.1016/j.case.2021.12.002Abstract Full Text Full Text PDF Google Scholar clearly demonstrates the imaging of sinus venosus defects. We agree with their statement: “Accurate diagnosis of the SVASD [sinus venosus atrial septal defect] and associated anomalies is essential for management.” However, their contention that “sinus venosus ASDs [atrial septal defects] are not amenable to percutaneous closure due to their complex anatomy” is no longer true. Percutaneous closure has been used since 2014. In 2020, after several case reports, two large single-center series appeared that were shortly thereafter followed by a multicenter series of 75 patients undergoing percutaneous correction.2Hansen J.H. Duong P. Jivanji S.G.M. Jones M. Kabir S. Butera G. et al.Transcatheter correction of superior sinus venosus atrial septal defects as an alternative to surgical treatment.J Am Coll Cardiol. 2020; 75: 1266-1278Crossref PubMed Scopus (27) Google Scholar, 3Sivakumar K. Qureshi S. Pavithran S. Vaidyanathan S. Rajendran M. Simple diagnostic tools may guide transcatheter closure of superior sinus venosus defects without advanced imaging techniques.Circ Cardiovasc Interv. 2020; 13: e009833Crossref PubMed Scopus (6) Google Scholar, 4Rosenthal E. Qureshi S.A. Jones M. Butera G. Sivakumar K. Boudjemline Y. et al.Correction of sinus venosus atrial septal defects with the 10 zig covered Cheatham-platinum stent: an international registry.Catheter Cardiovasc Interv. 2021; 98: 128-136Crossref PubMed Scopus (9) Google Scholar The use of transesophageal echocardiography to facilitate closure, by reducing the need for fluoroscopy and angiography considerably, has also been shown.5Kabir S.R. Simpson J.M. Jones M.I. Butera G. Qureshi S.A. Rosenthal E. TEE guidance during transcatheter treatment of superior sinus venosus ASDs with partial anomalous pulmonary venous drainage.JACC Cardiovasc Imaging. 2022; 15: 160-167Crossref PubMed Scopus (3) Google Scholar Currently, it appears that as many as 75% of superior sinus venosus atrial septal defects are amenable to percutaneous closure. Accurate imaging prior to and during the procedure is essential for case selection and guidance. Response to Letter to the Editor: Multimodality Imaging of Sinus Venosus Atrial Septal Defect: A Challenging Diagnosis in AdultsCASEVol. 6Issue 3PreviewWe appreciate the feedback by the letter’s authors. We agree with their comment that there are now percutaneous options for closing superior sinus venosus defects. We apologize for the editing error. The existing statement “Sinus venosus ASDs [atrial septal defects] are not amenable to percutaneous closure due to their complex anatomy” should have read, “Historically, sinus venosus ASDs were not amenable to percutaneous closure due to their complex anatomy. However, percutaneous options for closure of these defects have recently become available.”1-4 Full-Text PDF Open AccessMultimodality Imaging of Sinus Venosus Atrial Septal Defect: A Challenging Diagnosis in AdultsCASEVol. 6Issue 3PreviewCongenital heart disease is the most common congenital birth defect, affecting approximately nine per 1,000 live births.1 Atrial septal defects (ASDs) are among the most prevalent forms of congenital heart disease, comprising roughly 10% of cases.1 Of the several types of ASDs, secundum ASDs (75%) and primum ASDs (15%) occur most frequently. Sinus venosus ASD (SVASD) is a rare variant, accounting for 5%-10% of all ASDs.2 Full-Text PDF Open Access
No takes yet. Share an insight, caveat, or question.
Rosenthal et al. (2022) conducted a letter in Sinus venosus atrial septal defect. Percutaneous closure was evaluated. Contrary to historical beliefs, percutaneous closure is now a viable option for up to 75% of superior sinus venosus atrial septal defects, facilitated by transesophageal echocardiography.
Synapse has enriched 10 related papers. Consider them for comparative context: